J&J hunts for deals around the globe; ALung raises $9.5M for respiratory tech;

 @FierceMedDev: Endo's AMS owes $54.5M in vaginal mesh lawsuit. News | Follow @FierceMedDev

 @DamianFierce: Philips' is enduring its third ventilator recall in about a year, drawing a deadly FDA warning. Report | Follow @DamianFierce

 @MichaelGFierce: Biosensor nanoparticles deliver cancer drug with precise, 3-D imaging. FierceDrugDelivery story | Follow @MichaelGFierce

> Johnson & Johnson ($JNJ) is launching satellite offices around the globe to hunt for deals. Report

> ALung Technologies has raised $9.5 million to support its Hemolung respiratory assist system. Article

> NeuroSigma is launching its depression-treating Monarch eTNS device in Canada. More

> IncellDx has signed on with India's GeneCell Diagnostics to offer its HPV test in the country's growing market. Story (reg. req.)

> Sway Medical has emerged from stealth and raised $750,000 to support its FDA-cleared concussion-management app. News

Biotech News

 @FierceBiotech: ICYMI: 10 startups fueling pharma in social media. Special report | Follow @FierceBiotech

 @JohnCFierce: Under review and well past Ph3: Can Novartis gain anything from its latest breakthrough drug win at the FDA? Article | Follow @JohnCFierce

 @RyanMFierce: The news: Ablynx heads to PhI w/ German Merck. The takeaway: Misspell Merck Serono, and it rhymes with 'My Sharona." Story | Follow @RyanMFierce

 @EmilyMFierce: New at FierceBiotechResearch.com: Penn scientists create human-cell model of pancreatic cancer. Story | Follow @EmilyMFierce

> J&J spreads deal-making net with global ring of satellite offices. More

> Takeda asks FDA to OK its potential inflammatory bowel disease blockbuster. News

> Idenix plunges after FDA throws up a roadblock for lead hep C 'nuc.' Report

Pharma News

 @FiercePharma: Needy Forest Labs reportedly eyes a bid for Elan. But why? Yesterday's story | Follow @FiercePharma

 @EricPFierce: Who manufactures the top selling diabetes treatments? Novo has 5 of top 10, but not the top two. Special report | Follow @EricPFierce

> Pfizer's Viagra patent in Europe expires today. Article

> Teva's one-pill 'morning after' drug allowed OTC. Story

> Bristol-Myers Squibb gets a boost for leukemia drug Sprycel. Report